However, the results are conflicting; some trials showed benefit of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) to reduce AF occurrence, but others showed no effect [49, 50]. Here, ACE is linked to atrial fibrillation.